Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled

Zinger Key Points
  • Quantum-Si unveiled Platinum Pro, launching in 2025, with faster workflows and biopharma-focused custom tools.
  • Proteus, debuting in 2026, offers ultrasensitive proteomics and rapid sequencing to expand next-gen protein analysis.

Quantum-Si Inc QSI shares tanked over 12.8% Thursday morning.

The company plans to introduce Platinum Pro, an advanced version of its Platinum platform, in the first half of 2025. Platinum Pro will feature a streamlined workflow, reducing hands-on time and speeding up processing.

It will support both local and cloud-based data analysis, and introduce a ‘Pro Mode’ for custom application development, offering a valuable tool for biopharmaceutical clients.

On the other hand, Quantum-Si will launch Proteus in the second half of 2026.

Proteus is expected to offer advanced capabilities, including ultrasensitive detection of proteoforms, unbiased analysis of complex samples, and a new rapid sequencing chemistry that reduces run time to 90 minutes or less.

The company expects Proteus to serve as the foundational platform for scaling sequencing output, progressing from tens of millions of reads per sample at launch to billions over time.

CEO Jeff Hawkins expects Proteus to “open broad new markets for diverse applications in protein analysis, driving increased revenue growth that will create significant value for our shareholders.”

”With these technology advancements and partnerships in place, we believe we will be able to further extend our leadership position in next-generation protein sequencing while also extending into other areas of proteomics more generally.”

To accelerate the development of Proteus and mitigate risks in the hardware platform delivery, Quantum-Si recently announced new partnerships and collaborations.

Yesterday, Quantum-Si announced a collaboration with Nvidia to develop its new proteomics platform.

Also, the company entered into a distribution agreement with Avantor, as per which, Avantor will distribute Quantum-Si’s Next-Generation Protein Sequencing (NGPS) portfolio in the U.S. and Canada, offering researchers across various market segments easier access to these innovative proteomics solutions.

Price Action: Quantum-Si shares are down 12.88% at last check Thursday, trading around $1.21 a share.

Read Next:

Image via Quantum-Si

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!